Conditions: a 30G needle · tirzepatide · 10 mg/mL.
These are treated as interchangeable and I do not think they are.
If both are acceptable I would like to know that, so I can stop thinking about it.
Under what conditions does the answer flip?
At 10 mg/mL a 1 mg dose is 0.1 mL — 10 units on a U-100 barrel — and no needle gauge changes that number. Gauge changes three other things: how long the draw takes, how much stays behind in the hub, and how much rubber you core out of the stopper. On the 30G scale a larger number is a finer needle, so a 30G needle is fine enough that a viscous solution draws slowly and a hurried draw pulls bubbles. If you are drawing 10 units at a time, the dead space matters more than the bore: a fixed-needle barrel loses microlitres, a luer hub loses tens of them, and at 10 mg/mL each microlitre is 10 µg.
Answering this needs to know the viscosity of what is being drawn, since a viscous solution through a fine needle is slow enough to encourage bad technique.
Typical outer diameters: 21G is about 0.82 mm, 23G about 0.64 mm, 25G about 0.51 mm, 29G about 0.34 mm and 31G about 0.26 mm. The gauge number and the diameter move in opposite directions.
| Vial | Diluent | Concentration | 0.25 mg | 0.5 mg | 1 mg | 2.5 mg |
|---|---|---|---|---|---|---|
| 5 mg | 1 mL | 5 mg/mL | 5 u | 10 u | 20 u | 50 u |
| 5 mg | 2 mL | 2.5 mg/mL | 10 u | 20 u | 40 u | 100 u |
| 10 mg | 1 mL | 10 mg/mL | 2.5 u | 5 u | 10 u | 25 u |
| 10 mg | 2 mL | 5 mg/mL | 5 u | 10 u | 20 u | 50 u |
| 10 mg | 3 mL | 3.33 mg/mL | 7.5 u | 15 u | 30 u | 75 u |
Units are U-100 insulin units, where 1 unit = 0.01 mL. Divide dose by concentration for millilitres, then multiply by 100.
Very fine needles are more prone to bending and to blocking with any particulate, which is a practical argument for inspecting the solution before drawing.
Needle gauge to outer diameter correspondence is standardised and published; the inverse relationship between gauge number and diameter is the reason for the counter-intuitive labelling.
Nothing here is medical advice.
Angle the bevel and insert gently to avoid coring the stopper.
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemThis is a straightforward answer that people over-complicate because the numbering is counter-intuitive.
A 30G or 31G needle through a butyl stopper leaves a track that reseals, which is why fine-gauge repeated entry is tolerable and coarse-gauge repeated entry is not.
Stated carefully, drawing a viscous or foamy solution through a fine needle takes long enough that people rush the plunger, which causes more foaming. Using a wider drawing needle is the fix.
Higher gauge is not automatically better; it is thinner, which has costs as well as benefits.
Big to draw, small to inject, never the same one twice.
Start with the fact that gauge numbers run backwards — a higher number is a thinner needle — which is the source of half the confusion in this tag.
Stopper coring — punching a disc of rubber into the solution — is a large-bore phenomenon. An 18G or 21G needle inserted straight and fast is the classic way to do it; inserting at a slight angle with the bevel up reduces the risk.
Fixed-needle insulin syringes are supplied in 29G to 31G and cannot be swapped for drawing, which is the trade-off against their much lower dead space.
Butyl rubber closures are specified for resealing after piercing up to a stated gauge, which is the basis for the fine-gauge repeated-entry practice.
If a solution will not draw through a 25G needle, the problem is the solution rather than the needle.
Gauge numbers run backwards. Higher number, thinner needle.
Worth being precise here: for a 4 mm pen-style needle the gauge options are narrow and the choice is nearly made for you.
For injecting, 29G to 31G is the usual range and the difference in perceived discomfort between them is small. Needle length matters more than gauge for comfort at these volumes.
The caveat is that no gauge choice makes a non-sterile preparation safe, and research-use compounds are not approved for human use.
Flow goes as the fourth power of radius. That is why the difference feels so large.
The honest answer is that injection gauge is a comfort decision and drawing gauge is a stopper-coring decision.
Flow through a needle scales with the fourth power of the internal radius under the Hagen–Poiseuille relation. Halving the radius reduces flow sixteen-fold at the same pressure, which is why a 31G needle draws so much more slowly than a 21G.
The Hagen–Poiseuille relation gives flow proportional to the fourth power of radius, which is the quantitative basis for every gauge recommendation here.
None of the above is a recommendation to administer anything. Research-use-only material is not approved for human use, and the arithmetic being correct does not make the decision safe.
Length affects comfort more than gauge does at these volumes.
edited 5 Oct 2025 by low_dead_space — tightened the wording; no substantive change
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.